Injecto A/S: Financial statements 2022
CVR: 38729888
Source: annual report 2022, Danish Business Authority
01/09/2021 – 31/08/2022
Injecto A/S (CVR 38729888) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -2,931,492 and a net result of DKK -4,086,418 compared with DKK -2,544,782 the year before. Equity in the 2022 report amounted to DKK -6,991,649.
- Gross Profit
- DKK -2,931,492
- Profit/Loss
- DKK -4,086,418
- Equity
- DKK -6,991,649
- Total Assets
- DKK 2,443,111
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -2.9 mio. | -4.1 mio. | -7 mio. | - |
| 2021 | - | -2 mio. | -2.5 mio. | -2.9 mio. | - |
| 2020 | - | -2.5 mio. | -2.5 mio. | -360 t. | - |
| 2019 | - | -19 t. | -31 t. | 2.1 mio. | - |
Official annual report
Keep an eye on Injecto A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Injecto A/S has published its annual report for 2021. Gross profit came to DKK -1,984,229, and the net result was DKK -2,544,782.
About Injecto A/S
Injecto A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Lubrigone A/S. The management consists of Torben Helmer Knudsen. The board consists of John Holger Adamsen (chair), Carsten Sylvester Larsen and Torben Helmer Knudsen. The company is owned by Injecto Group A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,590,948 and a net result of DKK -2,942,694 compared with DKK -2,982,525 the year before. Equity in the 2025 report amounted to DKK -43,454.